What is he best known for?
The fields of study he is best known for:
Jun Zhang focuses on Virology, Hepatitis E virus, Virus, Immunology and Antibody.
His biological study spans a wide range of topics, including Epitope, Antigen, Monoclonal antibody and Genotype.
Jun Zhang has researched Hepatitis E virus in several fields, including Hepatitis E, Seroprevalence, Viral protein and Recombinant DNA.
His studies in Virus integrate themes in fields like Endocytosis and Hepatitis.
His Antibody research incorporates themes from Cell culture and Novel virus.
His Seroconversion research incorporates elements of Serology and Immunity.
His most cited work include:
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. (1279 citations)
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial (482 citations)
- Long-Term Efficacy of a Hepatitis E Vaccine (199 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Antibody, Virus, Hepatitis E virus and Epitope.
His Virology research includes elements of Molecular biology, Hepatitis E, Monoclonal antibody and Immunogenicity.
His Monoclonal antibody research focuses on subjects like Antigenicity, which are linked to Adjuvant.
His Antibody study is concerned with the larger field of Immunology.
Jun Zhang is studying Titer, which is a component of Virus.
His Hepatitis E virus study introduces a deeper knowledge of Genotype.
He most often published in these fields:
- Virology (60.38%)
- Antibody (29.38%)
- Virus (23.45%)
What were the highlights of his more recent work (between 2018-2021)?
- Virology (60.38%)
- Antibody (29.38%)
- Virus (23.45%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Virology, Antibody, Virus, Immunogenicity and Severe acute respiratory syndrome coronavirus 2.
His Virology study combines topics from a wide range of disciplines, such as Monoclonal antibody, Antigen and Hepatitis E virus.
The various areas that he examines in his Monoclonal antibody study include Epitope and Antigenicity.
Antibody is the subject of his research, which falls under Immunology.
His Virus study integrates concerns from other disciplines, such as Immunoassay and In vitro.
His Immunogenicity research integrates issues from Bivalent and Escherichia coli.
Between 2018 and 2021, his most popular works were:
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. (1279 citations)
- Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. (190 citations)
- CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. (87 citations)
In his most recent research, the most cited papers focused on:
Antibody, Virology, Virus, Internal medicine and Serology are his primary areas of study.
The subject of his Antibody research is within the realm of Immunology.
His work deals with themes such as Cirrhosis and Stem cell, which intersect with Immunology.
Jun Zhang has included themes like Epitope and Monoclonal antibody in his Virology study.
The study incorporates disciplines such as Tumor microenvironment and Immunoglobulin class switching in addition to Virus.
Jun Zhang works mostly in the field of Serology, limiting it down to concerns involving Seroconversion and, occasionally, Antibody response.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
